Indian perspective of remdesivir: A promising COVID-19 drug
- PMID: 32874008
- PMCID: PMC7446682
- DOI: 10.4103/ijp.IJP_486_20
Indian perspective of remdesivir: A promising COVID-19 drug
Conflict of interest statement
There are no conflicts of interest.
Comment on
-
A pneumonia outbreak associated with a new coronavirus of probable bat origin.Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3. Nature. 2020. PMID: 32015507 Free PMC article.
References
-
- Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the Treatment of Covid-19-Preliminary Report. N Engl J Med. 2020 In press. - PubMed
-
- Voluntary Licensing Agreements for Remdesivir. [Last accessed on 2020 May 20]. Available from: https://wwwgileadcom/purpose/advancing-global-health/covid-19/voluntary-... .
-
- FDA Fact Sheet for Health Care Providers Emergency Use Authorization (EUA) of Remdesivir (gs-5734tm) [Last accessed on 2020 May 20]. Available from: https://wwwfdagov/media/137566/download .
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
